Patient-centered health care using pharmacist-delivered medication therapy management in rural Mississippi

Ross, Leigh Ann; Bloodworth, Lauren S.

doi:10.1331/japha.2012.10192

Cited by 18 publications

(12 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 47 (41%) economic evaluations focused on general pharmacotherapeutic management (Table S1). Most studies used study designs with a high risk of bias—38% were single‐group posttest, 15% were nonrandomized posttest using a historical control group, and 11% were single‐group pretest‐posttest. Study designs with a medium risk of bias comprised the rest of the studies: 15% were nonrandomized pretest‐posttest and 11% were nonrandomized posttest.…”

Section: Resultsmentioning

confidence: 99%

Economic evaluations of clinical pharmacy services in the United States: 2011‐2017

Talon

Pérez

Yan

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Studies evaluating the cost-effectiveness of clinical pharmacy services (CPS) are needed to justify implementation and reimbursement. Through a systematic review, we describe services provided by pharmacists and their economic outcomes. We conducted a literature search of published studies in PubMed, Ovid, and Embase from January 2011 through December 2017. Manuscripts evaluating a CPS with patient-level economic outcomes and conducted in the United States were included. Study risks of bias were classified by study design characteristics. Economic evaluations were classified according to the presence of a comparator, and cost and outcome measures included. The quality of full economic evaluations was assessed using the Quality of Health Economic Studies (QHES) instrument. Descriptive statistics were used to summarize CPS characteristics. After screening, 115 studies wereincluded. Type of service provided included general pharmacotherapy (41%), disease management (30%), and targeted drug program (17%). Settings included hospital (34%), ambulatory care (28%), and community pharmacy (17%). Study designs were considered high risk of bias (use of a historical control group or no control group) in 69% of cases while 25% were medium risk of bias (non-randomized with a concurrent control group) and 6% were low risk of bias (randomized experimental or multigroup interrupted time series). Economic evaluation types were descriptive studies that measured cost and/or outcomes of a CPS (55%), comparative studies that measured cost or outcomes of a CPS and a comparator (37%), and full evaluations that measured cost and outcomes of a CPS and a comparator (8%). Among nine full evaluations, the median (range) QHES score was 74 (59-95) and four reported the CPS as being more effective at a lower cost. Few full economic evaluations were conducted, but supported the cost-effectiveness of CPS. Use of a comparator group and measurement of economic inputs and outcomes would strengthen the body of evidence. K E Y W O R D Scost-benefit analysis, health services research, pharmacoeconomics, pharmacy

show abstract

Section: Resultsmentioning

confidence: 99%

Economic evaluations of clinical pharmacy services in the United States: 2011‐2017

Talon

Pérez

Yan

et al. 2019

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…While provider outreach was a strong focus for year 2 of the project, there was limited discussion and detail regarding interaction with providers and how providers were part of the program's design. 16 Another publication detailed a pharmacy's experience integrating into a PCMH; however, this pharmacy was co-located to the primary care office and the designated pharmacist was physically located in the clinic rather than the pharmacy. 17 Therefore, the experience cannot be generalized to the current industry, but the innovative services provide interesting ideas on how community pharmacists can engage with a primary care office.…”

Section: Collaboration Opportunities For Community Pharmacistsmentioning

confidence: 99%

A model to inform community pharmacy's collaboration in outpatient care

Smith

Ferreri

2016

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

“…Pharmacist involvement in rural health care is making a difference in many areas of the country. Medication therapy management services have proven to be beneficial in rural communities, especially areas where chronic disease states are prevalent and primary care providers are lacking [5]. Studies suggest that a pharmacist may be a patient's first access to health care in rural areas [6].…”

Section: Original Articlementioning

confidence: 99%

Practice Characteristics and Geographic Distribution of Clinical Pharmacist Practitioners in North Carolina

Hale

Murawski

Ives

2015

North Carolina Medical Journal

View full text Add to dashboard Cite

show abstract

Patient-centered health care using pharmacist-delivered medication therapy management in rural Mississippi

Cited by 18 publications

References 11 publications

Economic evaluations of clinical pharmacy services in the United States: 2011‐2017

Economic evaluations of clinical pharmacy services in the United States: 2011‐2017

A model to inform community pharmacy's collaboration in outpatient care

Practice Characteristics and Geographic Distribution of Clinical Pharmacist Practitioners in North Carolina

Contact Info

Product

Resources

About